J Ferrières

Author PubWeight™ 80.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003 3.55
2 Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 2006 2.11
3 Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993. Heart 2000 1.97
4 Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas 2009 1.61
5 Leisure-time physical activity and regular walking or cycling to work are associated with adiposity and 5 y weight gain in middle-aged men: the PRIME Study. Int J Obes Relat Metab Disord 2001 1.53
6 Sex differences in awareness and control of hypertension in France. J Hypertens 1997 1.49
7 Differences in use of coronary angiography and outcome of myocardial infarction in Toulouse (France) and Gerona (Spain). The MONICA-Toulouse and REGICOR investigators. Eur Heart J 2000 1.38
8 Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001 1.29
9 Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol 2004 1.22
10 Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. J Am Coll Cardiol 1997 1.14
11 Different alcohol drinking and blood pressure relationships in France and Northern Ireland: The PRIME Study. Hypertension 2001 1.08
12 Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey. Circulation 1999 1.04
13 Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey. Heart 2002 1.02
14 An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients. AIDS 2001 0.99
15 The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab 2003 0.98
16 Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 2005 0.96
17 Influence of parental history of hypertension on blood pressure. J Hum Hypertens 1999 0.95
18 Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study. J Hum Hypertens 2010 0.95
19 Sedentary behaviour, physical activity and dietary patterns are independently associated with the metabolic syndrome. Diabetes Metab 2012 0.95
20 Depressed mood and dietary fish intake: direct relationship or indirect relationship as a result of diet and lifestyle? J Affect Disord 2007 0.95
21 Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost 1998 0.94
22 Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy. J Clin Endocrinol Metab 2001 0.93
23 Paraoxonase activity in two healthy populations with differing rates of coronary heart disease. Eur J Clin Invest 2000 0.92
24 Eating frequency and body fatness in middle-aged men. Int J Obes Relat Metab Disord 2002 0.92
25 Change in cardiovascular risk factors in France, 1985-1997. Eur J Epidemiol 2004 0.92
26 Association between liver X receptor alpha gene polymorphisms and risk of metabolic syndrome in French populations. Int J Obes (Lond) 2008 0.91
27 The North-East-South gradient of coronary heart disease mortality and case fatality rates in France is consistent with a similar gradient in risk factor clusters. Eur J Epidemiol 2000 0.91
28 Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thromb Vasc Biol 1997 0.91
29 Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study. Heart 2009 0.91
30 Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur Heart J 1999 0.90
31 Variability of ankle-arm index in general population according to its mode of calculation. Int Angiol 2002 0.90
32 Creatininuria in asthmatic children treated with a combination of glucocorticoid and beta-agonist. J Asthma 2003 0.90
33 Influence of alcohol consumption and various beverages on waist girth and waist-to-hip ratio in a sample of French men and women. Int J Obes Relat Metab Disord 1998 0.88
34 Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health 2002 0.88
35 [Assessment and characteristics of chronic renal insufficiency in France]. Ann Cardiol Angeiol (Paris) 2012 0.87
36 [Baseline characteristics and management of patients less than 45 years of age hospitalized for acute coronary syndromes: results from the nationwide French PREVENIR 1 and PREVENIR 2 studies]. Ann Cardiol Angeiol (Paris) 2002 0.87
37 Is hospital care involved in inequalities in coronary heart disease mortality? Results from the French WHO-MONICA Project in men aged 30-64. J Epidemiol Community Health 1998 0.86
38 Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study. Atherosclerosis 2007 0.86
39 Evaluation of oral health related to body mass index. Oral Dis 2012 0.84
40 Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: the PRIME study. Atherosclerosis 2011 0.84
41 Influence of parental histories of cardiovascular risk factors on risk factor clusters in the offspring. Diabetes Metab 2001 0.83
42 Triggering of acute coronary syndromes after a chemical plant explosion. Heart 2006 0.83
43 Association between the frequency of fruit and vegetable consumption and cardiovascular disease in male smokers and non-smokers. Eur J Clin Nutr 2010 0.83
44 Do lifestyle behaviours explain socioeconomic differences in all-cause mortality, and fatal and non-fatal cardiovascular events? Evidence from middle aged men in France and Northern Ireland in the PRIME Study. Prev Med 2012 0.83
45 Trends in coronary heart disease morbidity and mortality and acute coronary care and case fatality from 1985-1989 in southern Germany and south-western France. Eur Heart J 1997 0.82
46 Epidemiology of myocardial infarction in France: therapeutic and prognostic implications of heart failure during the acute phase. Am Heart J 1999 0.82
47 [Trends in the screening and management of hyertension and hypercholesterolemia in men in Haute-Garonne]. Rev Epidemiol Sante Publique 1996 0.82
48 Characteristics of male vitamin supplement users aged 50-59 years in France and Northern Ireland: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Int J Vitam Nutr Res 2000 0.82
49 [Epidemiology of myocardial infarction in France. One-year survival in the Usik study]. Arch Mal Coeur Vaiss 1998 0.81
50 [Epidemiology according to the European and French scales of myocardial infarction. Data of the MONICA project]. Arch Mal Coeur Vaiss 1996 0.81
51 Do cardiovascular risk factors in men depend on their spouses' occupational category? Eur J Epidemiol 2001 0.81
52 Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland. A nested case-control study from the PRIME cohort. Diabetes Metab 2006 0.80
53 Catechin in the Mediterranean diet: vegetable, fruit or wine? Atherosclerosis 2000 0.80
54 [Cardiovascular risk factors and shift work in men living in Haute-Garonne, France]. Arch Mal Coeur Vaiss 1998 0.80
55 Trends and geographical disparities in coronary heart disease in France: are results concordant when different definitions of events are used? Int J Epidemiol 1999 0.80
56 Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study. Am J Med Genet 2001 0.79
57 [Orange skin and xanthomas associated with lycopenaemia in a setting of type III dyslipoproteinemia]. Ann Dermatol Venereol 2008 0.79
58 Association between angiopoietin-like 6 (ANGPTL6) gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study. Diabetes Metab 2009 0.79
59 Association of macronutrient intake patterns with being overweight in a population-based random sample of men in France. Diabetes Metab 2009 0.79
60 Detection and management of associated atherothrombotic locations in patients with a recent atherothrombotic ischemic stroke: results of the DETECT survey. Cerebrovasc Dis 2005 0.78
61 Homocysteine and coronary heart disease risk in the PRIME study. Atherosclerosis 2006 0.78
62 [Distribution and treatment of cardiovascular risk factors in coronary patients: the Prevenir Study]. Arch Mal Coeur Vaiss 2001 0.78
63 Cancer mortality according to lipid-lowering drugs and lipoproteins in a general population. Curr Med Res Opin 2011 0.78
64 [Ankle-brachial index: an essential component for the screening, diagnosis and management of peripheral arterial disease]. Arch Mal Coeur Vaiss 2004 0.78
65 [Medical cost of cardiovascular risk factors prevention in France]. Arch Mal Coeur Vaiss 2002 0.78
66 Pulse wave velocity, pulse pressure and number of carotid or femoral plaques improve prediction of cardiovascular death in a population at low risk. J Hum Hypertens 2013 0.78
67 Trends in hypertension prevalence and management in Southwestern France, 1985-1996. J Clin Epidemiol 2000 0.78
68 [Trends in discharge prescriptions for patients hospitalized for acute coronary syndromes in France from 1995 to 2000. Data from the Usik 1995, Prevenir 1, Prevenir 2 and Usic 2000 surveys]. Ann Cardiol Angeiol (Paris) 2003 0.78
69 [Declared knowledge, beliefs and practices for cardiovascular disease prevention in the French population]. Rev Epidemiol Sante Publique 2001 0.78
70 Regional factors interact with educational and income tax levels to influence food intake in France. Eur J Clin Nutr 2011 0.77
71 Characteristics and six-month outcomes in a cohort of 8288 diabetic and non-diabetic patients with previous history of acute coronary syndrome or stroke: the French PREVENIR 3 survey. Diabetes Metab 2006 0.77
72 Exhaled NO in asthmatic children in unpolluted and urban environments. Environ Int 2001 0.77
73 Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective. Int J Clin Pract 2007 0.77
74 [Acute myocardial infarction in women. Initial characteristics, management and early outcome. The FAST-MI registry]. Ann Cardiol Angeiol (Paris) 2013 0.77
75 Why mortality from heart disease is low in France. Rates of coronary events are similar in France and Southern Europe. BMJ 2000 0.77
76 Human type II hyperlipoproteinemia enhances platelet-collagen adhesion in flowing nonanticoagulated blood. Arterioscler Thromb 1993 0.76
77 Contribution of lifetime smoking habit in France and Northern Ireland to country and socioeconomic differentials in mortality and cardiovascular incidence: the PRIME Study. J Epidemiol Community Health 2011 0.76
78 Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction Study. Atherosclerosis 2001 0.76
79 Lack of association between ADH3 polymorphism, alcohol intake, risk factors and carotid intima-media thickness. Atherosclerosis 2005 0.76
80 [Coronary mortality in France according to data sources]. Rev Epidemiol Sante Publique 2006 0.75
81 [Epidemiology of myocardial infarction in France. Regional specificities]. Arch Mal Coeur Vaiss 1997 0.75
82 REACH: from registry to harmonization. Arch Cardiovasc Dis 2008 0.75
83 Do calcium-channel blockers and glucocorticoids impair no production in ischaemic heart disease patients? Int J Cardiol 1997 0.75
84 Alcohol consumption patterns and body weight. Ann Nutr Metab 2013 0.75
85 Coronary heart disease epidemiology: a look towards the south. J Epidemiol Community Health 1998 0.75
86 Myocardial infarction rates are higher on weekends than on weekdays in middle aged French men. Heart 2001 0.75
87 [Production of oxygen free radicals in myocardial infarction treated by thrombolysis. Analysis of glutathione peroxidase, superoxide dismutase and malondialdehyde]. Arch Mal Coeur Vaiss 1994 0.75
88 Use of drug eluting stents: expert consensus of the French Society of Cardiology. Arch Cardiovasc Dis 2008 0.75
89 [Clinical and therapeutic specificities of myocardial infarction in patients with peripheral arterial disease: the USIC 2000 registry]. Ann Cardiol Angeiol (Paris) 2005 0.75
90 [Evaluation of the prevalence and management of normocholesterolaemic and non coronary hypertensives in France]. Arch Mal Coeur Vaiss 2005 0.75
91 [Ankle-brachial index: a marker of atherosclerosis and cardiovascular prognosis]. Arch Mal Coeur Vaiss 2004 0.75
92 [Characteristics of patients with coronary disease and aspirin prescription in Haute-Garonne]. Ann Cardiol Angeiol (Paris) 1994 0.75
93 [Acute severe coxsackie virus B myocarditis of pseudonecrotic form. Apropos of 2 cases]. Ann Cardiol Angeiol (Paris) 1993 0.75
94 [Prescriptions following acute coronary syndrome]. Arch Mal Coeur Vaiss 2005 0.75
95 [Characteristics of patients hospitalized for myocardial infarction in France with respect to left ventricular dysfunction. Results of the USIK study]. Arch Mal Coeur Vaiss 1997 0.75
96 [Infarction in patients aged over 70. Apropos of 194 patients]. Ann Cardiol Angeiol (Paris) 1994 0.75
97 Optimizing the prescription of statins after an acute coronary syndrome: the influence of coronary angioplasty and total cholesterol levels. Cardiovasc Drugs Ther 2001 0.75
98 Type A behaviour and consumption of an atherogenic diet: no association in the PRIME study. Appetite 2007 0.75
99 Serum nitrates and creatinine in workers exposed to atmospheric nitrogen oxides and ammonia. Sci Total Environ 1998 0.75
100 Exhaled NH3 and excreted Nh4+ in children in unpolluted or urban environments. Environ Int 2002 0.75
101 [Antiaggregants, aspirin, myocardial infarction and coronary deaths in the Haute-Garonne area]. Arch Mal Coeur Vaiss 1995 0.75
102 [Treatments of ischemic cardiopathies (IC) and modalities of prescription of aspirin in the three French MONICA centers in 1990]. Ann Cardiol Angeiol (Paris) 1995 0.75
103 [Value of continuous measurement of mixed venous oxygen saturation (SVO2) during coronary angioplasty]. Arch Mal Coeur Vaiss 1993 0.75
104 [Role of HDL cholesterol in the prediction of exercise stress test abnormalities in asymptomatic high-risk patients]. Arch Mal Coeur Vaiss 2001 0.75
105 Trends in overweight and obesity in middle-aged subjects from southwestern France, 1985-1997. Int J Obes Relat Metab Disord 2002 0.75
106 [Renal hemosiderosis caused by chronic hemolysis in a patient with a Saint-Jude mitral valve prosthesis]. Arch Mal Coeur Vaiss 1993 0.75
107 [Long-term effects of prescription drugs in 174 patients treated for myocardial infarction, followed up from 4 to 5 years (the DEVENIR study)]. Arch Mal Coeur Vaiss 1996 0.75
108 [Management of the cardiology patient with polyvascular disease: PRISMA study]. Arch Mal Coeur Vaiss 2004 0.75
109 [The best of epidemiology and cardiovascular prevention in 2006]. Arch Mal Coeur Vaiss 2007 0.75
110 [Chronic obliterative arterial disease of the lower limbs in the coronary patient: prevalence and prognostic incidence. The Monica Toulouse register]. Rev Med Interne 1999 0.75
111 Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: the prime study. Thromb Res 2001 0.75
112 [Exercise stress testing and primary prevention]. Arch Mal Coeur Vaiss 2006 0.75
113 [Hypercholesterolemia, practical guidelines]. Presse Med 2004 0.75
114 [Cost of cardiovascular risk factor prevention in middle-aged French men. The PRIME study]. Rev Epidemiol Sante Publique 2001 0.75
115 Atmospheric NO, temperature and ischaemic heart disease. Study in Toulouse and its conurbation. Sci Total Environ 2000 0.75
116 Nutritional intakes of 1072 French free-living men with and without diagnosed cardiovascular risk factors. Eur J Clin Nutr 2004 0.75
117 [When should an association of lipid-lowering drugs be proposed in a patient failing to reach therapeutic targets under monotherapy? Guidelines of the New French Society of Atherosclerosis]. Arch Mal Coeur Vaiss 2007 0.75
118 Associations between classical cardiovascular risk factors and coronary artery disease in two countries at contrasting risk for myocardial infarction: the PRIME study. Int J Cardiol 2000 0.75
119 [Influence of percutaneous coronary intervention in non ST-elevation acute coronary syndromes on prescription of secondary prevention medications. Data from the S-Témoin Registry]. Ann Cardiol Angeiol (Paris) 2007 0.75
120 Prevalence of late potentials in a sample of 487 healthy, middle-aged men from southwestern France. Pacing Clin Electrophysiol 2000 0.75
121 Transdermal estrogen replacement therapy and plasma lipids in 693 French women. Maturitas 1998 0.75
122 [Time for implementation of hypolipemiant treatment in patient with dyslipidemia in general medicine: results of the Prysme study]. Ann Cardiol Angeiol (Paris) 2011 0.75
123 [Dyslipidemia in women after 50: age, menopause or both?]. Ann Cardiol Angeiol (Paris) 2008 0.75
124 [The best of epidemiology and cardiovascular prevention in 2005]. Arch Mal Coeur Vaiss 2006 0.75
125 Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME study. J Hum Hypertens 2000 0.75